Effects of BRS and LRS on Postoperative Acute Kidney Injury
BRS/LRS
Effects of Sodium Bicarbonate Ringer's Injection and Sodium Lactated Ringer's Injection on Postoperative Acute Kidney Injury in Patients Undergoing Major Abdominal Surgery: a Randomized, Controlled, Open-label Clinical Study
1 other identifier
interventional
3,400
1 country
1
Brief Summary
- 1.Title: Effects of Sodium Bicarbonate Ringer's Injection and Sodium Lactated Ringer's Injection on postoperative acute kidney injury in patients undergoing major abdominal surgery: a randomized, controlled, open-label clinical study
- 2.Objective: To evaluate the effect of BRS and LRS infusion on acute renal injury in patients undergoing major abdominal surgery
- 3.Primary outcome: Incidence of AKI at 28 days postoperative (defined as acute kidney injury, according to Kidgo 2012 definition and classification).
- 4.Study Design: Randomized, controlled, open-label clinical study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jun 2021
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2021
CompletedFirst Posted
Study publicly available on registry
April 8, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedApril 12, 2023
April 1, 2023
2 years
April 6, 2021
April 11, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative acute renal injury
The incidence of AKI at 28 days after surgery (Acute kidney injury is defined and graded according to KIDGO 2012)
28 days after surgery
Study Arms (2)
Sodium Bicarbonate Ringer's Injection group
EXPERIMENTALIntraoperative fluid therapy performed with BRS (Sodium Bicarbonate Ringer's Injection)
Sodium Lactated Ringer's Injection group
ACTIVE COMPARATORIntraoperative fluid therapy performed with LRS (Sodium Lactated Ringer's Injection)
Interventions
Intraoperative fluid therapy performed with BRS (Sodium Bicarbonate Ringer's Injection)
Intraoperative fluid therapy performed with LRS (Sodium Lactated Ringer's Injection)
Eligibility Criteria
You may qualify if:
- ASA grade Ⅰ-Ⅲ.
- patients aged between 20 and 70, signed informed consent form, and are willing to participate in the study.
- BMI ≤ 30kg/m2.
- elective major abdominal surgery for the first time (radical resection of ovarian cancer, radical resection of cervical cancer, radical resection of gastric cancer, radical resection of colorectal cancer, radical resection of bladder tumor and radical resection of prostate tumor).
- NYHA cardiac function grade Ⅰ-Ⅲ.
- the function of liver and kidney is normal before operation.
- the blood coagulation function was normal before operation.
- hemoglobin \> 70g/L.
- sinus rhythm was detected by electrocardiogram and there were no other malignant arrhythmias.
You may not qualify if:
- Emergency surgery.
- liver and kidney surgery.
- complicated with chronic respiratory diseases and FEV1/FVC \< 70%.
- the operation time is less than 2 hours.
- patients with mental illness or cognitive impairment.
- uncontrolled hypertension with blood pressure higher than 180 × 100mmHg.
- patients with hypothyroidism.
- pregnant or lactating patients. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tongji Hospitallead
Study Sites (1)
Tongji hospital
Wuhan, Hubei, 27-430030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shiyong Li
Tongji Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Associate professor
Study Record Dates
First Submitted
April 6, 2021
First Posted
April 8, 2021
Study Start
June 1, 2021
Primary Completion
June 1, 2023
Study Completion
August 1, 2023
Last Updated
April 12, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share